Definitive Healthcare Corp. Class A Common Stock

Day range

$1.05 – $1.12

Open

$1.08

Prev close

$1.08

Volume

437.3K

Market cap

$115.28M

Shares out

106.74M

P/E

—

P/S

0.50

P/B

0.80

P/FCF

4.04

ROE

-116.3%

ROA

-33.9%

Debt/Equity

1.11

Div yield

0.28%

As of Oct 23, 2026

• Director appointmentSep 2, 2026

  On August 28, 2026, the Board ... appointed Clay Ritchey as the Company's Chief Executive Officer and as a member of the Board, effective September 8, 2026.

• Listing deficiency noticeJun 24, 2026

  On June 18, 2026, Definitive Healthcare Corp. received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that, based upon the closing bid price of the Company's common stock for the 30 consecutive business days from May 6, 2026 to June 17, 2026, the Company no longer meets the minimum bid price requirement of $1.00 per share set forth in Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Global Select Market.

• Annual meeting resultsJun 5, 2026

  On June 4, 2026, Definitive Healthcare Corp. held its 2026 Annual Meeting of Stockholders. At the Annual Meeting, the stockholders of the Company (i) elected each of the Company's nominees for Class II directors, each to serve a three-year term expiring at the 2029 annual meeting of stockholders; (ii) ratified the selection of Deloitte & Touche LLP as the Company's independent auditor for fiscal year 2026; (iii) approved an amendment to the Definitive Healthcare Corp. 2021 Equity Incentive Plan to increase the number of shares by 15,000,000; and (iv) approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers.

• Deal terminationApr 9, 2026

  On April 3, 2026, the Company and Spectrum entered into a termination agreement that permanently and irrevocably terminated the Nominating Agreement in its entirety.

• Director departureApr 3, 2026

  On March 30, 2026, Jeff Haywood resigned from the Board of Directors (the "Board") of Definitive Healthcare Corp. (the "Company") and as a member of the Human Capital Management and Compensation Committee (the "Compensation Committee") of the Board, effective immediately. Mr. Haywood's resignation was not the result of any disagreements with the Company relating to the Company's operations, policies or practices.

Days to cover

1.4

Short interest

1.68M

Avg volume

1.17M

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
  neutralGlobeNewswire Inc.· Apr 4, 2025
• INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors
  negativeBenzinga· Sep 3, 2024
• The Law Offices of Frank R. Cruz Announces Investigation of Definitive Healthcare Corp. (DH) on Behalf of Investors
  negativeBenzinga· Aug 28, 2024
• United Kingdom Healthcare Market Report 2024: The Role of Private Payers and Independent Sector Providers, Alongside the Public Sector, in the Funding and Delivery of UK Health and Care Services
  neutralGlobeNewswire Inc.· Aug 7, 2024
• Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  GlobeNewswire Inc.· Jun 25, 2024